2. Anti-infection
  3. Influenza Virus
  4. Influenza virus-IN-6

Influenza virus-IN-6 (Compound 35) is a potent influenza N-terminal domain of the polymerase acidic protein subunit (PAN) endonuclease inhibitor with an IC50 of 0.20 μM.

For research use only. We do not sell to patients.

Influenza virus-IN-6 Chemical Structure

Influenza virus-IN-6 Chemical Structure

CAS No. : 2919303-26-5

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Influenza virus-IN-6 Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Influenza virus-IN-6 (Compound 35) is a potent influenza N-terminal domain of the polymerase acidic protein subunit (PAN) endonuclease inhibitor with an IC50 of 0.20 μM[1].

IC50 & Target

IC50: 0.20 μM (PAN)[1]
KD: 56.02 nM (PAN)[1]
In Vitro

Influenza virus-IN-6 (Compound 35) (48 h) shows anti-influenza virus activity in MDCK cells with EC50s of 1.28 ± 0.35, 1.12 ± 0.65, 0.76 ± 0.11 and 0.43 ± 0.06 μM against H1N1, H5N1, H3N2 and Flu B, respectively[1].
Influenza virus-IN-6 (5-20 μM; 24 h) affects virus replication but not virus particles, cells, and adsorption[1].
Influenza virus-IN-6 (2.5-10 μM; 24 h) inhibits influenza viral polymerase activity[1].
Influenza virus-IN-6 displayed promising stability in mouse plasma, liver microsomes, and intestinal S9-UDPGA[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Influenza virus-IN-6 Related Antibodies

Western Blot Analysis[1]

Cell Line: MDCK cells
Concentration: 5, 10 and 20 μM
Incubation Time: 24 h
Result: Decreased nucleoprotein (NP) and matrix protein 2 (M2).

RT-PCR[1]

Cell Line: MDCK cells
Concentration: 2.5, 5, 10 and 20 μM
Incubation Time: 24 h
Result: Decreased the expression of viral NP mRNA in a well-defined dose-dependent manner. Inhibited cRNA synthesis in a dose-dependent fashion.
In Vivo

Influenza virus-IN-6 (Compound 35) (7.5-30 mg/kg/d; i.p.; twice daily for 7 days) markedly protects mice from influenza virus infection[1].
Pharmacokinetic (PK) Profile In Vivo of Influenza virus-IN-6 (Compound 35) after a Single Dose in Rats In Vivo (n = 5)a[1]

parameter IV (2 mg/kg) PO (10 mg/kg) IP (15 mg/kg)
T1/2 (h) 0.33 ± 0.07 0.82 ± 0.16 1.07 ± 0.25
Tmax (h) NA 0.52 0.45
Cmax (ng/mL) 1586.55 ± 366.48 92.20 ± 36.25 889.52 ± 233.17
AUC0-t (h·ng/mL) 536.45 ± 58.72 164.30 ± 26.37 790.62 ± 188.31
CL (mL/min/kg) 53.76 ± 13.18 NA NA
F % NA 6.13% 29.50%

aIV represents intravenous injection, IP represents intraperitoneal injection, and PO represents the gastrointestinal route. T1/2 is the half-life of the compound exposure in plasma. Tmax is the time taken to reach the maximum concentration. Cmax represents the highest observed concentration. AUC (0–t) is the area under the curve. CL (mL/min/kg) is the clearance. F % is the percent bioavailability.

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Balb/C mice, H1N1 infection model[1]
Dosage: 0, 7.5, 15, and 30 mg/kg/d
Administration: Intraperitoneal injection, twice per day for 7 days
Result: Exhibited excellent anti-IAV activity in vivo at a dose of 30 mg/kg/d. Still showed potent antiviral activity in vivo, with a survival ratio of approximately 60% against lethal virus infection in mice at 15 mg/kg/d.
Animal Model: SD rats[1]
Dosage: 2, 10 or 15 mg/kg
Administration: IV, IP, or PO (Pharmacokinetic Analysis)
Result: Showed good pharmacokinetic profiles.
Molecular Weight

511.95

Formula

C27H26ClNO7
CAS No.
SMILES

CCCOC([C@@H]1CC2=CC(O)=C(C=C2[C@@H](N1C(C3=CC=CC=C3Cl)=O)CC4=CC=C(C(O)=C4)O)O)=O
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Influenza virus-IN-6 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Influenza virus-IN-62919303-26-5Influenza VirusMDCKPAN endonucleaseH1N1H5N1H3N2Flu BInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Influenza virus-IN-6
Cat. No.:
HY-152078
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (0 KB) Français - FR (0 KB) Deutsch - DE (0 KB) Norwegian - NO (0 KB) Español - ES (0 KB) Swedish - SV (0 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.